Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 9 studies | 27% ± 10% | |
GABAergic neuron | 6 studies | 34% ± 13% | |
macrophage | 6 studies | 29% ± 13% | |
interneuron | 5 studies | 34% ± 22% | |
fibroblast | 5 studies | 20% ± 4% | |
microglial cell | 4 studies | 20% ± 4% | |
glutamatergic neuron | 4 studies | 46% ± 13% | |
endothelial cell | 3 studies | 26% ± 13% | |
GABAergic interneuron | 3 studies | 20% ± 4% | |
neuron | 3 studies | 23% ± 5% | |
dendritic cell | 3 studies | 18% ± 1% | |
alveolar macrophage | 3 studies | 20% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 31% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 504.90 | 180 / 180 | 95% | 11.78 | 409 / 430 |
bladder | 100% | 548.10 | 21 / 21 | 95% | 13.00 | 478 / 504 |
breast | 100% | 451.97 | 459 / 459 | 94% | 12.11 | 1049 / 1118 |
brain | 95% | 389.00 | 2509 / 2642 | 99% | 15.19 | 696 / 705 |
esophagus | 100% | 396.23 | 1441 / 1445 | 93% | 11.36 | 170 / 183 |
thymus | 99% | 292.28 | 646 / 653 | 92% | 7.19 | 555 / 605 |
kidney | 100% | 338.47 | 89 / 89 | 90% | 12.28 | 814 / 901 |
intestine | 100% | 454.31 | 966 / 966 | 90% | 9.35 | 475 / 527 |
stomach | 99% | 344.94 | 356 / 359 | 90% | 9.05 | 258 / 286 |
lung | 100% | 546.04 | 576 / 578 | 89% | 11.59 | 1024 / 1155 |
uterus | 100% | 583.27 | 170 / 170 | 85% | 11.86 | 392 / 459 |
adrenal gland | 100% | 454.37 | 257 / 258 | 78% | 6.73 | 179 / 230 |
skin | 100% | 912.79 | 1808 / 1809 | 56% | 4.14 | 264 / 472 |
pancreas | 39% | 54.07 | 128 / 328 | 97% | 9.91 | 173 / 178 |
prostate | 98% | 300.87 | 239 / 245 | 38% | 1.73 | 189 / 502 |
blood vessel | 100% | 433.70 | 1332 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 482.30 | 1201 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 368.90 | 844 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 13.44 | 44 / 45 |
muscle | 97% | 250.28 | 778 / 803 | 0% | 0 | 0 / 0 |
spleen | 95% | 186.46 | 230 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 66% | 4.21 | 19 / 29 |
peripheral blood | 28% | 343.05 | 264 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 25% | 1.06 | 20 / 80 |
liver | 9% | 12.36 | 20 / 226 | 15% | 0.97 | 61 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0016779 | Molecular function | nucleotidyltransferase activity |
GO_0045296 | Molecular function | cadherin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MB21D2 |
Protein name | Nucleotidyltransferase MB21D2 (EC 2.7.7.-) (Mab-21 domain-containing protein 2) (hMB21D2) |
Synonyms | C3orf59 |
Description | FUNCTION: Probable nucleotidyltransferase that catalyzes the formation of cyclic dinucleotide second messenger in response to some unknown stimulus. . |
Accessions | ENST00000392452.3 Q8IYB1 |